NCT04174300

Brief Summary

Fibromyalgia (FM)and Chronic Fatigue Syndrome (CFS) are complex diseases often presenting overlapping symptomatology. Manual therapy (MT) protocols report benefits for pain treatment of FM, but the underlying mechanisms for patient improvement remain unknown. The main goal of this study is to assess the molecular changes associating to mechanical and additional MT triggers, possibly involved in patient symptom improvement.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 20, 2019

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

November 20, 2019

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 22, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 10, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 10, 2020

Completed
Last Updated

August 27, 2020

Status Verified

August 1, 2020

Enrollment Period

12 months

First QC Date

November 20, 2019

Last Update Submit

August 25, 2020

Conditions

Keywords

Manual TherapyPhysiotherapyFibromyalgia (FM)Chronic Fatigue Syndrome (CFS)RNAseqmicroRNAmechanomiR

Outcome Measures

Primary Outcomes (3)

  • Fatigue score

    MFI, 1-5 scale (20 items), higher scores indicate higher degree of fatigue

    8 weeks

  • Pain index

    FIQ and Visual analogue scale (VAS) of pain, Scale 0-100, \<39 mild, 39-58 moderate, ≥59 severe

    8 weeks

  • Differential gene expression

    RNAseq

    8 weeks

Secondary Outcomes (2)

  • Quality of life score

    8 weeks

  • ANS (autonomic nervous system) dysfunction

    8 weeks

Other Outcomes (1)

  • Subjective response to treatment

    8 weeks

Study Arms (1)

Manual Therapy

EXPERIMENTAL

8 sessions of manual therapy (twice weekly) of 25 minutes including pressure maneuvers of about 4,5 N

Procedure: Manual Therapy

Interventions

8 sessions of manual therapy (twice weekly) of 25 minutes including pressure maneuvers of about 4,5 N

Also known as: Physiotherapy treatment
Manual Therapy

Eligibility Criteria

Age40 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Diagnosis of FM with or without comorbid CFS
  • Not receiving hormone therapy
  • Not suffering from other diseases
  • Without previous history of cancer
  • Not actively participating in any pharmacological trial
  • Not taking medication for at least 12 hours before blood draw
  • Having signed informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Clinicas Universitarias UCV

Valencia, 46001, Spain

Location

Related Publications (1)

  • Espejo JA, Garcia-Escudero M, Oltra E. Unraveling the Molecular Determinants of Manual Therapy: An Approach to Integrative Therapeutics for the Treatment of Fibromyalgia and Chronic Fatigue Syndrome/Myalgic Encephalomyelitis. Int J Mol Sci. 2018 Sep 9;19(9):2673. doi: 10.3390/ijms19092673.

    PMID: 30205597BACKGROUND

Related Links

MeSH Terms

Conditions

FibromyalgiaFatigue Syndrome, Chronic

Interventions

Musculoskeletal Manipulations

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesRheumatic DiseasesNeuromuscular DiseasesNervous System DiseasesEncephalomyelitisNeuroinflammatory DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeuticsPhysical Therapy ModalitiesRehabilitation

Study Officials

  • Maria Garcia-Escudero, PhD

    Catholic University of Valencia

    PRINCIPAL INVESTIGATOR
  • Elisa Oltra, PhD

    Catholic University of Valencia

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Masking Details
Outcome measures will be randomized and anonymized
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

November 20, 2019

First Posted

November 22, 2019

Study Start

March 20, 2019

Primary Completion

March 10, 2020

Study Completion

March 10, 2020

Last Updated

August 27, 2020

Record last verified: 2020-08

Data Sharing

IPD Sharing
Will not share

There is not a plan to make IPD available.

Locations